-
1دورية أكاديمية
المؤلفون: Scheen, André, Paquot, Nicolas, Lancellotti, Patrizio
المصدر: Revue Médicale de Liège, 79 (4), 260-264 (2024-04)
مصطلحات موضوعية: Hypoglycemic Agents, Glucagon-Like Peptide-1 Receptor, Humans, Diabetes Mellitus, Type 2/complications/drug therapy, Hypoglycemic Agents/therapeutic use, Cardiovascular System, Heart Failure/complications, Coronary Artery Disease/complications, Glucagon-Like Peptide-1 Receptor/agonists, Cardiovascular Diseases/complications, GLP-1 receptor agonist, Gliflozin, Heart failure, Myocardial Infarction, SGLT2 inhibitor, Type 2 diabetes, Human health sciences, Cardiovascular & respiratory systems, Sciences de la santé humaine, Systèmes cardiovasculaire & respiratoire
العلاقة: urn:issn:0370-629X; urn:issn:2566-1566
الوصول الحر: https://orbi.uliege.be/handle/2268/316759Test
-
2دورية أكاديمية
المؤلفون: Scheen, André
المصدر: Revue Médicale de Liège, 79 (3), 146-151 (2024-03)
مصطلحات موضوعية: Glucagon-Like Peptide-1 Receptor, Glucagon-Like Peptide-1 Receptor Agonists, Hypoglycemic Agents, Humans, Atherosclerosis/prevention & control/complications, Cardiovascular Diseases/prevention & control/chemically induced, Diabetes Mellitus, Type 2/complications/drug therapy, Glucagon-Like Peptide-1 Receptor/agonists, Hypoglycemic Agents/therapeutic use, Retrospective Studies, Risk Factors, Cardiovascular disease, Clinical practice, GLP-1 receptor agonist, Real-life, Type 2 diabetes, Underuse, Human health sciences, Endocrinology, metabolism & nutrition, Cardiovascular & respiratory systems, Pharmacy, pharmacology & toxicology, Sciences de la santé humaine, Endocrinologie, métabolisme & nutrition, Systèmes cardiovasculaire & respiratoire, Pharmacie, pharmacologie & toxicologie
العلاقة: urn:issn:0370-629X; urn:issn:2566-1566
الوصول الحر: https://orbi.uliege.be/handle/2268/318535Test
-
3دورية أكاديمية
المؤلفون: Scheen, André
المصدر: Expert Review of Clinical Pharmacology, 16 (11), 1053-1062 (2024)
مصطلحات موضوعية: Hypoglycemic Agents, Cardiotonic Agents, Glucagon-Like Peptide-1 Receptor, Humans, Hypoglycemic Agents/adverse effects, Diabetes Mellitus, Type 2/complications/drug therapy, Cardiotonic Agents/pharmacology, Heart Failure/drug therapy, Atherosclerosis/complications, Cardiovascular Diseases/prevention & control/complications, Glucagon-Like Peptide-1 Receptor/agonists, Atherosclerotic cardiovascular disease, GLP-1 receptor agonist, SGLT2 inhibitor, cardiovascular outcome trial, gliflozin, heart failure, real-world clinical practice, Human health sciences, Endocrinology, metabolism & nutrition, Pharmacy, pharmacology & toxicology, Cardiovascular & respiratory systems, Sciences de la santé humaine, Endocrinologie, métabolisme & nutrition, Pharmacie, pharmacologie & toxicologie, Systèmes cardiovasculaire & respiratoire
العلاقة: urn:issn:1751-2433; urn:issn:1751-2441
الوصول الحر: https://orbi.uliege.be/handle/2268/312538Test
-
4دورية أكاديمية
المؤلفون: Paquot, Nicolas
المصدر: Revue Médicale de Liège, 76 (12), 896-903 (2021-12)
مصطلحات موضوعية: Cardiovascular safety, Obesity – Glucagon, Semaglutide, Type 2 diabetes, 1, Oral administration, like peptide, Glucagon-Like Peptide-1 Receptor, Hypoglycemic Agents, semaglutide, Glucagon-Like Peptides, Humans, Diabetes Mellitus, Type 2/drug therapy, Human health sciences, Endocrinology, metabolism & nutrition, Sciences de la santé humaine, Endocrinologie, métabolisme & nutrition
العلاقة: urn:issn:0370-629X; urn:issn:2566-1566
الوصول الحر: https://orbi.uliege.be/handle/2268/296397Test
-
5دورية أكاديمية
المؤلفون: Scheen, André, DE FLINES, Jenny, Paquot, Nicolas
المصدر: Revue Médicale de Liège, 78 (3), 147-152 (2023-03)
مصطلحات موضوعية: Anti-Obesity Agents, Glucagon-Like Peptide 1, IY9XDZ35W2 (Glucose), Glucagon-Like Peptide-1 Receptor, Hypoglycemic Agents, Humans, Anti-Obesity Agents/pharmacology/therapeutic use, Diabetes Mellitus, Type 2/drug therapy, Glucagon-Like Peptide 1/pharmacology/therapeutic use, Obesity/drug therapy, Glucose/therapeutic use, Glucagon-Like Peptide-1 Receptor/agonists, Hypoglycemic Agents/therapeutic use, Anorectic drugs, Gastrointestinal peptides, Glucagon-like peptide-1, Obesity, Pharmacotherapy, Safety, Human health sciences, Endocrinology, metabolism & nutrition, Pharmacy, pharmacology & toxicology, Sciences de la santé humaine, Endocrinologie, métabolisme & nutrition, Pharmacie, pharmacologie & toxicologie
العلاقة: urn:issn:0370-629X; urn:issn:2566-1566
الوصول الحر: https://orbi.uliege.be/handle/2268/303516Test
-
6دورية أكاديمية
المؤلفون: Scheen, André, Paquot, Nicolas
المصدر: Vignette therapeutique. Quel traitement injectable apres echec du traitement oral chez le patient diabetique de type 2 ? Revue medicale de Liege, 75(1), 60-66., Belgium. (2020).
مصطلحات موضوعية: Administration, Oral, Diabetes Mellitus, Type 2/drug therapy, Glucagon-Like Peptide 1, Glucagon-Like Peptide-1 Receptor, Humans, Hypoglycemic Agents/administration & dosage, Insulin/administration & dosage, Combined therapy, GLP, Injectable therapy, Oral antidiabetic agents, Type 2 diabetes, 1 receptor agonist, Basal insulin, Human health sciences :: Pharmacy, pharmacology & toxicology, Sciences de la santé humaine :: Pharmacie, pharmacologie & toxicologie, Human health sciences :: Endocrinology, metabolism & nutrition, Sciences de la santé humaine :: Endocrinologie, métabolisme & nutrition
الوصول الحر: https://orbi.uliege.be/handle/2268/244073Test
-
7دورية أكاديمية
المصدر: Endocrinology, 164 (5) (2023-03-13)
مصطلحات موضوعية: GLP-1, insulin secretion, mouse, neprilysin, thiorphan, Glucagon-Like Peptide-1 Receptor, Glucose, Animals, Diabetes Mellitus, Type 2, Insulin/metabolism, Endocrinology, Human health sciences, Endocrinology, metabolism & nutrition, Sciences de la santé humaine, Endocrinologie, métabolisme & nutrition
العلاقة: https://academic.oup.com/endo/advance-article-pdf/doi/10.1210/endocr/bqad055/49632982/bqad055.pdfTest; urn:issn:0013-7227; urn:issn:1945-7170
الوصول الحر: https://orbi.uliege.be/handle/2268/302696Test
-
8دورية أكاديمية
المؤلفون: Scheen, André, Lefèbvre, Pierre
المصدر: The Lancet Diabetes and Endocrinology, 11 (2), 129-138 (2023-02)
مصطلحات موضوعية: Glucagon, Receptors, Glucagon, Glucagon-Like Peptide-1 Receptor, Glucagon-Like Peptide 1, Humans, Glucagon/physiology, Receptors, Glucagon/agonists/genetics, Diabetes Mellitus, Type 2/metabolism, Glucagon-Like Peptide 1/metabolism, Hypoglycemia, Human health sciences, Endocrinology, metabolism & nutrition, Sciences de la santé humaine, Endocrinologie, métabolisme & nutrition
العلاقة: urn:issn:2213-8587; urn:issn:2213-8595
الوصول الحر: https://orbi.uliege.be/handle/2268/300362Test
-
9دورية أكاديمية
المؤلفون: Scheen, André
المصدر: The lancet. Diabetes & endocrinology, 9 (9), 546-548 (2021)
مصطلحات موضوعية: Diabetes Mellitus, Type 2/drug therapy, Glucagon-Like Peptide-1 Receptor, Humans, Hypoglycemic Agents/adverse effects, Human health sciences, Endocrinology, metabolism & nutrition, Pharmacy, pharmacology & toxicology, Sciences de la santé humaine, Endocrinologie, métabolisme & nutrition, Pharmacie, pharmacologie & toxicologie
العلاقة: urn:issn:2213-8587; urn:issn:2213-8595
الوصول الحر: https://orbi.uliege.be/handle/2268/264367Test
-
10دورية أكاديمية
المؤلفون: Scheen, André, Paquot, Nicolas
المصدر: Revue Médicale Suisse, 17 (747), 1405-1410 (2021)
مصطلحات موضوعية: Diabetes Mellitus, Type 2/drug therapy, Glucagon-Like Peptide 1, Glucagon-Like Peptide-1 Receptor, Humans, Pharmaceutical Preparations, Weight Loss, Human health sciences, Endocrinology, metabolism & nutrition, Pharmacy, pharmacology & toxicology, Sciences de la santé humaine, Endocrinologie, métabolisme & nutrition, Pharmacie, pharmacologie & toxicologie
العلاقة: urn:issn:1660-9379
الوصول الحر: https://orbi.uliege.be/handle/2268/264349Test